We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00802594
First Posted: December 5, 2008
Last Update Posted: December 5, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Bill and Melinda Gates Foundation
Information provided by:
Immtech Pharmaceuticals, Inc